| FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma L Sehgal, R Mathur, FK Braun, JF Wise, Z Berkova, S Neelapu, LW Kwak, ... Leukemia 28 (12), 2376-2387, 2014 | 151 | 2014 |
| Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex JF Wise, Z Berkova, R Mathur, H Zhu, FK Braun, RH Tao, AL Sabichi, ... Blood, The Journal of the American Society of Hematology 121 (23), 4729-4739, 2013 | 88 | 2013 |
| An extended APOBEC3A mutation signature in cancer A Langenbucher, D Bowen, R Sakhtemani, E Bournique, JF Wise, L Zou, ... Nature communications 12 (1), 1602, 2021 | 78 | 2021 |
| Targeting nucleolin for better survival in diffuse large B-cell lymphoma N Jain, H Zhu, T Khashab, Q Ye, B George, R Mathur, RK Singh, ... Leukemia 32 (3), 663-674, 2018 | 35 | 2018 |
| Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein Z Berkova, S Wang, JF Wise, H Maeng, Y Ji, F Samaniego Journal of the National Cancer Institute 101 (6), 399-411, 2009 | 28 | 2009 |
| CD74 interferes with the expression of fas receptor on the surface of lymphoma cells Z Berkova, S Wang, X Ao, JF Wise, FK Braun, AH Rezaeian, L Sehgal, ... Journal of Experimental & Clinical Cancer Research 33, 1-10, 2014 | 21 | 2014 |
| PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo RH Tao, Z Berkova, JF Wise, AH Rezaeian, U Daniluk, X Ao, DH Hawke, ... Blood, The Journal of the American Society of Hematology 118 (11), 3107-3118, 2011 | 17 | 2011 |
| Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer M Stanzione, J Zhong, E Wong, TJ LaSalle, JF Wise, A Simoneau, ... Science Advances 8 (19), eabn1229, 2022 | 12 | 2022 |
| Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series JF Wise, S Nakken, CB Steen, D Vodák, G Trøen, B Johannessen, ... Blood advances 4 (9), 1859-1866, 2020 | 10 | 2020 |
| A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy CB Steen, E Leich, JH Myklebust, S Lockmer, JF Wise, BE Wahlin, ... haematologica 104 (10), e460, 2019 | 10 | 2019 |
| An extended APOBEC3A mutation signature in cancer. Nat. Commun. 12, 1602 A Langenbucher, D Bowen, R Sakhtemani, E Bournique, JF Wise, L Zou, ... | 5 | 2021 |
| The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells U Daniluk, C Kerros, RH Tao, JF Wise, X Ao, Z Berkova, F Samaniego Journal of Experimental & Clinical Cancer Research 31, 1-12, 2012 | 5 | 2012 |
| Huge whole-genome study of human metastatic cancers JF Wise, MS Lawrence Nature 575 (7781), 60-61, 2019 | 4 | 2019 |
| Genomes captured during tumour spread JF Wise, MS Lawrence Nature 575 (7781), 60-61, 2019 | 2 | 2019 |
| Discovery of recurrent mutations associated with chemo-immunotherapy relapse in diffuse large B-cell lymphoma JF Wise, S Nakken, D Vodak, G Trøen, OC Lingjærde, LA Meza-Zepeda, ... Blood, The Journal of the American Society of Hematology 126 (23), 110-110, 2015 | 2 | 2015 |
| Development of the Bushblok industry in Namibia JF Wise, RJ Sazanowicz, J Mahony, SF Feller Unpublished IQP Report. Worcester, MA: Worcester Polytechnic Institute, 2006 | 2 | 2006 |
| Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs S Pal Choudhuri, L Girard, JYS Lim, JF Wise, B Freitas, D Yang, E Wong, ... Cancer Discovery, OF1-OF24, 2024 | 1 | 2024 |
| Anti-CD74 antibody hLL1 is associated with lymphoma and chronic lymphocytic leukemia cell effects in vivo F Samaniego, JF Wise, L Fayad, M Fanale, F Hagemeister, V Selvaraj, ... Blood 118 (21), 1796, 2011 | 1 | 2011 |
| CD74 is a regulator of Fas-mediated apoptotic signaling Z Berkova, S Wang, J Wise, S Wang, R Tao, H Maeng, D Hawke, ... Blood, The Journal of the American Society of Hematology 112 (11), 2826-2826, 2008 | 1 | 2008 |
| Reduced Immune-Cell Infiltration in MHC Class I Negative DLBCL K Huse, Y Blaker, JF Wise, A Sharma, L Meriranta, KT Isaksen, ... Blood 142, 179, 2023 | | 2023 |
